Search

Home > New FDA Approvals > 052 - FDA approves Luxturna the first gene therapy to treat patients with an inherited disease, vision loss; FDA approves sNDA bosutinib for newly-diagnosed Ph+ CML; FDA approves cabozantinib for previously untreated advanced RCC


	Podcast:		New FDA Approvals
	Episode:		052 - FDA approves Luxturna the first gene therapy to treat patients with an inherited disease, vision loss; FDA approves sNDA bosutinib for newly-diagnosed Ph+ CML; FDA approves cabozantinib for previously untreated advanced RCC
	Category:		Science & Medicine
	Duration:		00:13:09
	Publish Date:		2017-12-20 07:00:00
	Description:		December 20, 2017 0:30 - FDA approves Luxturna voretigene (neparvovec-rzyl) a novel gene therapy to treat patients with a rare form of inherited vision loss https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm589467.htm http://ir.sparktx.com/news-releases/news-release-details/fda-approves-spark-therapeutics-luxturnatm-voretigene-neparvovec 6:32 - FDA approves sNDA bosutinib for newly-diagnosed Ph+ CML http://avillionllp.com/avillion-announces-us-approval-pfizers-bosulif/ http://press.pfizer.com/press-release/us-fda-approves-pfizers-bosulif-bosutinib-treatment-patients-newly-diagnosed-ph-chroni 9:40 - FDA approves Cabometyx cabozantinib s for previously untreated advanced renal cell carcinoma http://ir.exelixis.com/phoenix.zhtml?c=120923&p=irol-newsArticle&ID=2323419 http://www.onclive.com/web-exclusives/fda-approves-frontline-cabozantinib-for-advanced-rcc === NASCENT MEDICAL Nascent Medical, LLC, has a team of over 100 PhD-/MD-level writers who can write about any medical, scientific or technical topic. They do the following types of writing, including but not limited to: -Video and virtual reality script writing -eLearning scripts -Medical education -Webinar slide creation -Manuscripts -Slidesets -Manuscripts -Press releases -Blog posts -Annual reports -Proposals -White papers -Web content -Posters -Sales training materials contact info@nascentmc.com == The first episode of AI in medicine is coming out on Wednesday January 4th, 2018. I will be talking with Dr. Alex Zhavoronkov who is the is the CEO of InSilico Medicine, Inc a company utilizing big data analysis for aging research. https://itunes.apple.com/us/podcast/aimedicines-podcast/id1325232000?mt=2 The episode after that, I’ll be talking with Dawn Laney and Dave Jacob founders of ThinkGenetic.com a company uses artificial intelligence (AI) solutions to improve the speed to diagnosis. Then I will be covering Precision Medicine World conference taking place in Jan 2018 in Silicon Valley.
	Total Play:		0